What happened
KM Pharmaceutical disclosed a plan to buy back its own shares worth US$205K, about 6.6% of its market value.
For context, this equals about 6.6% of the company's market value.
| Buyback amount | US$205K |
|---|---|
| vs. market value | 6.6% |
| Filed | 2026-07-27, Material event report (treasury share acquisition) |
| Source | DART rcept 20260727000184 → open original filing |
Source: DART. Information only, not investment advice.